BPC-157 supports this interconnected system by: Strengthening tight junctions between intestinal epithelial cells, reducing intestinal permeability (leaky gut) Modulating the enteric nervous system to normalize motility and reduce visceral hypersensitivity Regulating mucosal immune responses to prevent inappropriate inflammation against dietary and microbial antigens Conditions Treated with Oral BPC-157 Beyond Symptom Relief: Addressing Root Causes Unlike proton pump inhibitors (PPIs) that suppress stomach acid or corticosteroids that broadly dampen immunity, BPC-157 works by restoring the underlying structural and functional integrity of the gastrointestinal tract
The results showed that CD patients had significantly reduced serum levels of key metabolites, including AAs, lipids, pyruvate, and choline, while glucose and 3-hydroxybutyric acid were elevated
Correlation between endogenous glutathione content and sensitivity of cultured human skin cells to radiation at defined wavelengths in the solar ultraviolet range
[DOI] [PubMed] [Google Scholar] 28.Li G., Qin Y., Cheng Z., Cheng X., Wang R., Luo X., Zhao Y., Zhang D., Li G
This shared mechanism is anticipated to play a significant role in drug resistance
